NRC
National Research Corp
NASDAQ: NRC · HEALTHCARE · HEALTH INFORMATION SERVICES
$18.71
+3.73% today
Updated 2026-06-04
Market cap
$431.35M
P/E ratio
49.08
P/S ratio
3.11x
EPS (TTM)
$0.39
Dividend yield
2.84%
52W range
$11 – $23
Volume
0.1M
National Research Corp (NRC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$18.71
12-Month target
$12.00
2030 Target
—
Intrinsic (DCF)
$27.80
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 0.61% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 6.52%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.